MA fines Abbott Australasia $100,000 for conduct breach

Abbott was also ordered to withdraw its claims about the popular product, including that it “significantly reduced CVD events”, MA said.The industry body said Abbott was in breach of sections of the code of conduct covering responsibility and “false or misleading claims” but was not in breach of the section of the code covering “discredit to and reduction of confidence in the industry”.

The complaint, from rival Merck Sharp and Dohme, called into question Abbott’s claim that Lipidil significantly reduced

Latest

Trending